Antisense Oligonucleotides (ASO)

Поділитися
Вставка
  • Опубліковано 12 жов 2022
  • Describes Antisense Oligonucleotide (ASO) technology and how it can be used to treat a variety of genetic disorders with no previous effective conventional therapy. Spinal Muscular Atrophy (SMA) and Lipoprotein (a) or Lp(a) are presented as examples.

КОМЕНТАРІ • 5